FindTrial
Sign In

Tislelizumab plus chemotherapy

DRUG2 trials

Sponsors

Wei Xu, Shandong Provincial Hospital

Conditions

Bone Cancer MetastaticCancer of Unknown PrimaryChemotherapy EffectGene Mutation-Related CancerImmune Evasion, TumorLocally Advanced Esophageal Squamous Cell CarcinomaTislelizumab

Phase 2

Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary
NCT05241132
Wei XuBone Cancer Metastatic, Cancer of Unknown Primary, Chemotherapy Effect +3
Start: 2021-11-12End: 2024-10-31Target: 27Updated: 2022-02-15

Unknown Phase

Efficacy and Safety of Tislelizumab Plus Chemotherapy as Conversion Therapy in Unresectable Locally Advanced ESCC
RecruitingNCT07549100
Shandong Provincial HospitalLocally Advanced Esophageal Squamous Cell Carcinoma
Start: 2023-05-15End: 2028-12-31Target: 30Updated: 2026-04-23